Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
John M. Mulvaney, MHA
Articles
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)
E. Thomas Carey, PharmD;Ryan A. Forrey, MS;Douglas Haughs, BS;Dawn Moore Jefferson, PharmD;James A. Jorgenson, RPh, MS;Derek M. McMichael, PharmD;John M. Mulvaney, MHA;Susan M. Spivey, Phar
December 11th 2011The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
Read More
Utility of the PhaSeal Closed System Drug Transfer Device
Derek M. McMichael, PharmD;Dawn Moore Jefferson, PharmD;E. Thomas Carey, PharmD;Ryan A. Forrey, PharmD, MS;Susan M. Spivey, PharmD, DDS;John M. Mulvaney, MHA;James A. Jorgenson, RPh, MS;R.
February 2nd 2011The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.
Read More
Latest Updated Articles
Published: October 23rd 2024 | Updated: October 24th 2024
What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Published: August 30th 2024 | Updated: November 21st 2024
Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report
Published: October 8th 2024 | Updated: November 21st 2024
What Drug Rates Are Reported in Price Transparency Data?
Published: October 7th 2024 | Updated: November 21st 2024
What Went Wrong: How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
